This site looks better in landscape mode! Turn your device on its side!

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

Over 2%

The burden to society of osteoarthritis in developed counties is more than 2% annual GDP

NEWS

New studies suggests APPA protects against joint damage

Read More

NEWS

APPA Phase II human study completes ahead of schedule

Read More

NEWS

Personalised Medicine & Disease Modification in OA

Read More